IRCT2014101318971N3已完成未知
Effect of Cyproheptadine on weight gain in underweight children ages 2-10 years old.
Zanjan University of Medical Science0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 10 years（—）
- 性别
- All
入选标准
- •Inclusion criteria include: all children aged 2 to 10 years with a weight below the 50th percentile; Children whose parents have given consent to participate in the study.
- •Exclusion criteria include: children with underlying organic condition (gastrointestinal, cardiovascular, respiratory, renal and nervous systems) causing growth failure; inappropriate use of medicines; discourage children from study; did not return for follow-up; occurs severe disease and side effects of medication.
排除标准
- 未提供
研究者
相似试验
Unknown
4 期
Cyproheptadine as an Appetite StimulantFailure to ThriveNCT01314989St. Justine's Hospital20
终止
4 期
Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding DisordersFeeding BehaviorsNCT02568007Medical College of Wisconsin4
已完成
2 期
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentCentral Nervous System TumorsCachexiaLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesUnspecified Childhood Solid Tumor, Protocol SpecificLymphomaBrain TumorNCT00066248University of South Florida70
尚未招募
3 期
Investigating the effect of cyproheptadine in chronic kidney patientsChronic kidney patients undergoing hemodialysis.Chronic kidney disease, stage 5N18.5IRCT20220329054368N2Yasouj University of Medical Sciences124
尚未招募
不适用
Weight gain in newborns following the adoption of the stoma refeeding techniqueintestinal failureACTRN12621000835842The Insides Company20